|Videos|April 19, 2017

What Can My Facility Do to Prevent Respiratory Viral HAIs?

Matt Linam, MD, MS, Assistant Professor, Pediatric Infectious Diseases, University of Arkansas for Medical Sciences, explains a strategy used at his healthcare facility to prevent respiratory viral HAIs in children.

Matt Linam, MD, MS, Assistant Professor, Pediatric Infectious Diseases, University of Arkansas for Medical Sciences, explains a strategy used at his healthcare facility to prevent respiratory viral HAIs in children.

Interview Transcript (slightly modified for readability)

“Trying to figure out how to prevent respiratory viral [healthcare-associated infections] HAIs in children can be a challenge. It’s kind of one of those things where you need to [get] everybody involved and try to engage other staff members. One of the things that we have done at our hospital is, we’ve engaged our unit secretaries.

We require all families and visitors to sign-in at the desk, [and] we’ve used that as an opportunity to provide some quick education for the family, as well as doing a quick health screen to make sure that they’re healthy enough to visit. That seems to have been, for us, a good strategy to get that education about being healthy and [get family and visitors to] performing hand hygiene right at the moment that they’re there, prior to when they actually enter the patient’s room.”


Related to this article

Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Measles Update: November 13, 2026
The latest CDC numbers show a 4.4% increase of measles cases from week-to-week. Hospitalizations have reached 591, or 11% of all 2026 cases, and the Pan American Health Organization is deciding this week whether the United States has lost its measles elimination status.
The Prospective Emergence of XDR Shigella Beyond High-Risk Groups
Los Angeles has been experiencing this challenging bacteria in recent years with the potential of it becoming carbapenem-resistant in the future. Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP), provides commentary about his team's work in this area and the role of genomic sequencing to uncover this troublesome pathogen.